Results 11 to 20 of about 73,861 (211)
Cancer Science, Volume 114, Issue 11, Page 4343-4354, November 2023., 2023 Gilteritinib demonstrated significantly improved antitumor efficacy tha alectinib against ALK‐rearranged NSCLC cells. Abstract Gilteritinib is a multitarget tyrosine kinase inhibitor (TKI), approved for the treatment of FLT3‐mutant acute myeloid leukemia, with a broad range of activity against several tyrosine kinases including anaplastic lymphoma ...
Chihiro Ando +20 more
wiley +1 more source
Nursing Open, Volume 9, Issue 3, Page 1612-1624, May 2022., 2022 Abstract Aim To develop self‐management support platform on mobile for Chinese patients with lung cancer. Design A stepwise approach with combination of methods. Methods Literature review was carried out to construct preliminary framework and develop detailed content for self‐management modules.
Xiaosha Ni +7 more
wiley +1 more source
Clinical features and outcomes of patients with stage I multiple primary lung cancers
Cancer Science, Volume 112, Issue 5, Page 1924-1935, May 2021., 2021 This study determined the clinical features and outcomes of synchronous and metachronous multiple primary lung cancer. This information could have major implications regarding diagnosis and identification of independent prognostic factors, and provide valuable information for postoperative management of patients with multiple primary lung cancer ...
Yasushi Shintani +16 more
wiley +1 more source
Cancer Medicine, Volume 10, Issue 3, Page 1043-1056, February 2021., 2021 No significant difference was seen in any anticancer treatments in solid tumor subgroup. Chemotherapy, however, will lead to a higher mortality in patients with hematological malignancies. Abstract Background The relationship between cancer and COVID‐19 has been revealed during the pandemic.
Hanqing Liu +6 more
wiley +1 more source
Chinese Medical Entity Recognition Model Based on Character and Word Vector Fusion
Scientific Programming, Volume 2021, Issue 1, 2021., 2021 The medical information carried in electronic medical records has high clinical research value, and medical named entity recognition is the key to extracting valuable information from large‐scale medical texts. At present, most of the studies on Chinese medical named entity recognition are based on character vector model or word vector model.
Qinghui Zhang +5 more
wiley +1 more source
Cancer Science, Volume 111, Issue 5, Page 1685-1691, May 2020., 2020 This study provides the benchmark statistics on medically treated patients with lung cancer in Japan. Here, 3‐year survival rates of patients treated with concurrent chemoradiotherapy (n = 1689), sequential chemoradiotherapy (n = 221), thoracic radiotherapy alone (n = 662), chemotherapy alone (n = 7790) and palliative care alone (n = 1952) were 43.6 ...
Ikuo Sekine +12 more
wiley +1 more source
PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer. [PDF]
, 2015 BackgroundMaintenance of genomic integrity is essential to ensure normal organismal development and to prevent diseases such as cancer. PR-Set7 (also known as Set8) is a cell cycle regulated enzyme that catalyses monomethylation of histone 4 at Lys20 ...
Au, Alfred +7 more
core +2 more sources
Review of the Role of EBUS-TBNA for the Pulmonologist, Including Lung Cancer Staging [PDF]
, 2010 This review focuses on the role of endobronchial ultrasound-guided transbronchial needle aspiration in day-to-day pulmonology practice. Case examples are given of the common indications for endobronchial ultrasound-guided transbronchial needle aspiration
Alan HODGSON +4 more
core +1 more source
Cancer Medicine, Volume 8, Issue 4, Page 1521-1529, April 2019., 2019 It remains unclear EGFR‐mutated patients who have clinical outcomes of Immune checkpoint inhibitors (ICIs). In this study, we revealed the clinical factor of ICI responders among EGFR‐mutated NSCLC. Uncommon mutation and without T790M mutation are associated to ICI efficacy.
Tadaaki Yamada +16 more
wiley +1 more source